Suchbegriffe: AQUAPORIN-4, . Treffer: 8
Geraldes, R; Ciccarelli, O; Barkhof, F; De Stefano, N; Enzinger, C; Filippi, M; Hofer, M; Paul, F; Preziosa, P; Rovira, A; DeLuca, GC; Kappos, L; Yousry, T; Fazekas, F; Frederiksen, J; Gasperini, C; Sastre-Garriga, J; Evangelou, N; Palace, J; MAGNIMS study group
The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
NAT REV NEUROL. 2018; 14(4): 199-213.
Doi: 10.1038/nrneurol.2018.14
Web of Science
PubMed
FullText
FullText_MUG
Lechner, C; Baumann, M; Hennes, EM; Schanda, K; Marquard, K; Karenfort, M; Leiz, S; Pohl, D; Venkateswaran, S; Pritsch, M; Koch, J; Schimmel, M; Häusler, M; Klein, A; Blaschek, A; Thiels, C; Lücke, T; Gruber-Sedlmayr, U; Kornek, B; Hahn, A; Leypoldt, F; Sandrieser, T; Gallwitz, H; Stoffels, J; Korenke, C; Reindl, M; Rostásy, K
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
J Neurol Neurosurg Psychiatry. 2016; 87(8):897-905
Doi: 10.1136/jnnp-2015-311743
Web of Science
PubMed
FullText
FullText_MUG
Tuller, F; Holzer, H; Schanda, K; Aboulenein-Djamshidian, F; Höftberger, R; Khalil, M; Seifert-Held, T; Leutmezer, F; Berger, T; Reindl, M
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
J Neuroinflammation. 2016; 13(1):176-176
Doi: 10.1186/s12974-016-0642-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Aboul-Enein, F; Seifert-Held, T; Mader, S; Kuenz, B; Lutterotti, A; Rauschka, H; Rommer, P; Leutmezer, F; Vass, K; Flamm-Horak, A; Stepansky, R; Lang, W; Fertl, E; Schlager, T; Heller, T; Eggers, C; Safoschnik, G; Fuchs, S; Kraus, J; Assar, H; Guggenberger, S; Reisz, M; Schnabl, P; Komposch, M; Simschitz, P; Skrobal, A; Moser, A; Jeschow, M; Stadlbauer, D; Freimüller, M; Guger, M; Schmidegg, S; Franta, C; Weiser, V; Koppi, S; Niederkorn-Duft, M; Raber, B; Schmeissner, I; Jecel, J; Tinchon, A; Storch, MK; Reindl, M; Berger, T; Kristoferitsch, W
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.
PLoS One. 2013; 8(11):e79649-e79649
Doi: 10.1371/journal.pone.0079649
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fairless, R; Williams, SK; Hoffmann, DB; Stojic, A; Hochmeister, S; Schmitz, F; Storch, MK; Diem, R
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
J Neurosci. 2012; 32(16): 5585-5597.
Doi: 10.1523/JNEUROSCI.5705-11.2012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jarius, S; Jacobi, C; de Seze, J; Zephir, H; Paul, F; Franciotta, D; Rommer, P; Mader, S; Kleiter, I; Reindl, M; Akman-Demir, G; Seifert-Held, T; Kristoferitsch, W; Melms, A; Wandinger, KP; Wildemann, B
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Mult Scler. 2011; 17(9): 1067-1073.
Doi: 10.1177/1352458511403958
Web of Science
PubMed
FullText
FullText_MUG
Mader, S; Gredler, V; Schanda, K; Rostasy, K; Dujmovic, I; Pfaller, K; Lutterotti, A; Jarius, S; Di Pauli, F; Kuenz, B; Ehling, R; Hegen, H; Deisenhammer, F; Aboul-Enein, F; Storch, MK; Koson, P; Drulovic, J; Kristoferitsch, W; Berger, T; Reindl, M
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
J Neuroinflammation. 2011; 8(7):184-184
Doi: 10.1186/1742-2094-8-184
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mader, S; Lutterotti, A; Di Pauli, F; Kuenz, B; Schanda, K; Aboul-Enein, F; Khalil, M; Storch, MK; Jarius, S; Kristoferitsch, W; Berger, T; Reindl, M
Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
PLOS ONE. 2010; 5(5): e10455-e10455.
Doi: 10.1371/journal.pone.0010455
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar